{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:28:32Z","timestamp":1770899312232,"version":"3.50.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1586\/14760584.3.5.533","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T11:35:03Z","timestamp":1105616103000},"page":"533-540","source":"Crossref","is-referenced-by-count":9,"title":["Control and lot release of meningococcal group C conjugate vaccines"],"prefix":"10.1586","volume":"3","author":[{"given":"Janet","family":"Suker","sequence":"first","affiliation":[{"name":"National Institute for Biological Standards and Control, Blanche Lane, South Mimms Potters Bar, EN6 3QG, UK. jsuker@nibsc.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M","family":"Feavers","sequence":"additional","affiliation":[{"name":"National Institute for Biological Standards and Control, Blanche Lane, South Mimms Potters Bar, EN6 3QG, UK. ifeavers@nibsc.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Corbel","sequence":"additional","affiliation":[{"name":"National Institute for Biological Standards and Control, Blanche Lane, South Mimms Potters Bar, EN6 3QG, UK. mcorbel@nibsc.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Jones","sequence":"additional","affiliation":[{"name":"National Institute for Biological Standards and Control, Blanche Lane, South Mimms Potters Bar, EN6 3QG, UK. cjones@nibsc.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bolgiano","sequence":"additional","affiliation":[{"name":"National Institute for Biological Standards and Control, Blanche Lane, South Mimms Potters Bar, EN6 3QG, UK. bbolgiano@nibsc.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"e_1_2_1_5_1","first-page":"S118\u2014S124","article-title":"Broome CV","volume":"2","author":"Schwartz B","year":"1989","unstructured":"Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2, S118\u2014S124 (1989).","journal-title":"Global epidemiology of meningococcal disease. Clin. Microbiol. Rev"},{"issue":"1","key":"e_1_2_1_6_1","first-page":"75","article-title":"Meningococcal vaccines. Expert Rev","volume":"1","author":"Bethell D","year":"2002","unstructured":"Bethell D, Pollard AJ. Meningococcal vaccines. Expert Rev. Vaccines 1(1), 75\u201384 (2002).","journal-title":"Vaccines"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Riddell A Buttery J. Vaccines against meningococcal disease: current and future technologies. Expert Opin. Biol. Ther.1(3) 385\u2013399 (2001).","DOI":"10.1517\/14712598.1.3.385"},{"key":"e_1_2_1_8_1","unstructured":"Granoff DM Feavers IM Borrow R. Meningococcal Vaccines. In: Vaccines. Plotkin SA Orenstein WA (Eds). Saunders PA USA 959\u2013987 (2004)."},{"key":"e_1_2_1_9_1","first-page":"1307","article-title":"Artenstein MS","volume":"129","author":"Goldschneider I","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129,1307\u20131326 (1969).","journal-title":"Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med"},{"key":"e_1_2_1_10_1","first-page":"1327","article-title":"Artenstein MS","volume":"129","author":"Goldschneider I","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129,1327\u20131348 (1969).","journal-title":"Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med"},{"key":"e_1_2_1_11_1","first-page":"673","article-title":"Gotschlich EC","volume":"60","author":"Lepow ML","year":"1977","unstructured":"Lepow ML, Goldschneider I, Gold R, Randolph M, Gotschlich EC. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 60,673\u2013680 (1977).","journal-title":"Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Gold R Lepow ML Goldschneider I Draper TF Gotshlich EC. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect. Dis. 140(5) 690\u2013697 (1979).","DOI":"10.1093\/infdis\/140.5.690"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"Gold R Lepow ML Goldschneider I Gotschlich EC. Immune response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. Infect. Dis. 136 (Suppl.) 531\u2014S35 (1977).","DOI":"10.1093\/infdis\/136.Supplement.S31"},{"key":"e_1_2_1_14_1","first-page":"4352","article-title":"Murine immune response to the Neisseria meningitidis group C capsular polysaccharide","volume":"141","author":"Rubinstein LJ","year":"1988","unstructured":"Rubinstein LJ, Stein KE. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. I. Ontogeny. Immunol. 141,4352\u20134356 (1988).","journal-title":"I. Ontogeny. Immunol"},{"key":"e_1_2_1_15_1","first-page":"125","article-title":"Immunization and the maturation of infant immune responses","volume":"95","author":"Goldblatt D","year":"1998","unstructured":"Goldblatt D. Immunization and the maturation of infant immune responses. Dev. Biol. Stand. 95,125\u2013132 (1998).","journal-title":"Dev. Biol. Stand"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165 (Sunni. 1) S49\u2014S52 (1992).","DOI":"10.1093\/infdis\/165-Supplement_1-S49"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Goldblatt D Borrow R Miller E. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidisserogroup C in young adults. J Infect. Dis. 185(3) 397\u2013400 (2002).","DOI":"10.1086\/338474"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr. Infect. Dis. 1.17\\(Suppl. 9) S117\u2014S122 (1998).","DOI":"10.1097\/00006454-199809001-00005"},{"key":"e_1_2_1_19_1","first-page":"592","article-title":"Anttila M","volume":"340","author":"Peltola H","year":"1992","unstructured":"Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus intluenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet340, 592\u2013594 (1992).","journal-title":"Rapid disappearance of Haemophilus intluenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet"},{"key":"e_1_2_1_20_1","first-page":"4927","article-title":"Bovre K etal","volume":"83","author":"Caugant DA","year":"1986","unstructured":"Caugant DA, Froholm LO, Bovre K etal. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Nat\/Acad. Sci. USA 83,4927\u20134931 (1986).","journal-title":"Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Nat\/Acad. Sci. USA"},{"key":"e_1_2_1_21_1","first-page":"641","article-title":"Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers","volume":"132","author":"Caugant DA","year":"1986","unstructured":"Caugant DA, Bovre K, Gaustad P et al. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen. Microbial. 132,641\u2013652 (1986).","journal-title":"J Gen. Microbial"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","unstructured":"Wang J-F Caugant DA Morelli G Koumar\u00e9 B Achtman M. Antigenic and epidemiological properties of the ET-37 complex of Neisseria meningitidis. J. Infect. Dis. 167 1320-1329 (1993).","DOI":"10.1093\/infdis\/167.6.1320"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","unstructured":"Miller E Salisbury D Ramsay M. Planning registration and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20 (Suppl. I) S58\u2014S67 (2001).","DOI":"10.1016\/S0264-410X(01)00299-7"},{"issue":"1","key":"e_1_2_1_24_1","first-page":"77","article-title":"Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev","volume":"3","author":"Balmer P","year":"2004","unstructured":"Balmer P, Borrow R. Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert Rev. Vaccines 3 (1), 77\u201387 (2004).","journal-title":"Vaccines"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/biol.2000.0253"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00097-8"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","unstructured":"Borrow R Goldblatt D Andrews N Richmond P Southern J Miller E. Influence of prior meningococcal c polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J. Infect. Dis. 184(3) 377\u2013380 (2001).","DOI":"10.1086\/322024"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Richmond P Borrow R Goldblatt D et al. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect. Dis. 183(1) 160\u2013163 (2001).","DOI":"10.1086\/317646"},{"issue":"2","key":"e_1_2_1_29_1","first-page":"761","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiyeness in adults that is overcome by meningococcal C conjugate vaccine. J Infect","volume":"181","author":"Richmond P","year":"2000","unstructured":"Richmond P, Kaczmarski E, Borrow R et al. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiyeness in adults that is overcome by meningococcal C conjugate vaccine. J Infect. Dis. 181(2), 761\u2013764 (2000).","journal-title":"Dis"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00050-5"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00241-3"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.21.2795"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","unstructured":"Bramley JC Hall T Finn A et al. Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2 3 and 4 months of age. Vaccine 19(20\u201322) 2924\u20132931 (2001).","DOI":"10.1016\/S0264-410X(00)00528-4"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00050-0"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","unstructured":"Balmer P Borrow R Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med. Microbiol. 51(9) 717\u2013722 (2002).","DOI":"10.1099\/0022-1317-51-9-717"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","unstructured":"Ramsay ME Andrews NJ Trotter CL Kaczmarski EB Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Br. Med. 326 (7385) 365\u2013366 (2003).","DOI":"10.1136\/bmj.326.7385.365"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","unstructured":"Maiden MC Stuart JM. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359 (9320) 1829\u20131831 (2002).","DOI":"10.1016\/S0140-6736(02)08679-8"},{"key":"e_1_2_1_38_1","first-page":"353","article-title":"Assuring the quality and safety of vaccines: regulatory licensing and batch release","volume":"87","author":"Griffiths E","year":"2003","unstructured":"Griffiths E, Knezevic I. Assuring the quality and safety of vaccines: regulatory licensing and batch release. Methods Mol. Med. 87, 353\u2013376 (2003).","journal-title":"Methods Mol. Med"},{"key":"e_1_2_1_39_1","unstructured":"\u2022 Describes issues for regulation and quality control of vaccines in general."},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","unstructured":"Milstien J Dellepiane N Lambert S et al. Vaccine quality \u2014 can a single standard be defined? Vaccine 20(7\u20138) 1000\u20131003 (2002).","DOI":"10.1016\/S0264-410X(01)00422-4"},{"key":"e_1_2_1_41_1","unstructured":"\u2022 Describes issues for regulation and quality control of vaccines in general."},{"key":"e_1_2_1_42_1","unstructured":"Recommendations for the production and control of Hib conjugate vaccines. WHO Technical Report Series 897 27\u201356 (2000)."},{"key":"e_1_2_1_43_1","first-page":"143","article-title":"Yost SE","volume":"87","author":"Jones C","year":"1996","unstructured":"Jones C, Crane DT, Lemercinier X, Bolgiano B, Yost SE. Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccines. Dev. Biol. Stand. 87,143\u2013151 (1996).","journal-title":"Physicochemical studies of the structure and stability of polysaccharide-protein conjugate vaccines. Dev. Biol. Stand"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90219-4"},{"key":"e_1_2_1_45_1","doi-asserted-by":"crossref","unstructured":"Jumel K Ho MM Bolgiano B. Evaluation of meningococcal C oligosaccharide conjugate vaccines by size-exclusion chromatography\/multi-angle laser light scattering. Biotechnol. Appl. Biochem. 36(3) 219\u2013226 (2002).","DOI":"10.1042\/BA20020066"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","unstructured":"Ho MM Bolgiano B Corbel MJ. Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRN\/1197 conjugate vaccines. Vaccine 19(7\u20138) 716\u2013725 (2000).","DOI":"10.1016\/S0264-410X(00)00261-9"},{"key":"e_1_2_1_47_1","unstructured":"\u2022 Describes useful methods for the control testing of MenC vaccines and illustrates the correlation between physicochemical and immunogenicity data."},{"key":"e_1_2_1_48_1","unstructured":"Hsieh CL. Characterization of saccharide-CRM197 conjugate vaccines. Dev. Biol. Biol. (Basel) 103 93\u2013104 (2000)."},{"key":"e_1_2_1_49_1","unstructured":"\u2022 Describes useful approaches for testing MenC and pneumococcal conjugates."},{"key":"e_1_2_1_50_1","first-page":"259","article-title":"Quantification of free polysaccharide in meningococcal polysaccharide--diphtheria toxoid conjugate vaccines","volume":"103","author":"Lei QP","year":"2000","unstructured":"Lei QP, Shannon AG, Heller RK, Lamb DH. Quantification of free polysaccharide in meningococcal polysaccharide--diphtheria toxoid conjugate vaccines. Dev. Biol. (Basel)103,259\u2013264 (2000).","journal-title":"Dev. Biol. (Basel"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.4.2378-2382.2001"},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","unstructured":"Glade MP Lewin EB Sutton A et al. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coil K92 in adult volunteers. J Infect. Dis. 139 52-59 (1979).","DOI":"10.1093\/infdis\/139.1.52"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(96)00253-4"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00462-4"},{"key":"e_1_2_1_55_1","first-page":"121","article-title":"Austin S","volume":"103","author":"Jones C","year":"2000","unstructured":"Jones C, Lemercinier X, Crane DT, Gee CK, Austin S. Spectroscopic studies of the structure and stability of glycoconjugate vaccines. Dev. Biol. Masel)103,121\u2013136 (2000).","journal-title":"Spectroscopic studies of the structure and stability of glycoconjugate vaccines. Dev. Biol. Masel"},{"key":"e_1_2_1_56_1","doi-asserted-by":"crossref","unstructured":"Bolgiano B Mawas F Yost SE et al. Effect of physicochemical modification on the immunogenicity of Haemophilus intiuenzae type b oligosaccharide\u2014CRM197 conjugate vaccines. Vaccine 19(23\u201324) 3189\u20133200 (2001).","DOI":"10.1016\/S0264-410X(01)00024-X"},{"key":"e_1_2_1_57_1","first-page":"139","article-title":"Monitoring stability of meningococcal group C conjugate vaccines; correlation of physicochemical methods and immunogenicity assays","volume":"103","author":"Ho MM","year":"2000","unstructured":"Ho MM, Lemercinier X, Bolgiano B, Corbel MJ. Monitoring stability of meningococcal group C conjugate vaccines; correlation of physicochemical methods and immunogenicity assays. Dev. Biol. (Basel)103,139\u2013150 (2000).","journal-title":"Dev. Biol. (Basel"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00342-0"},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","unstructured":"Hendriksen CF. Refinement reduction and replacement of animal use for regulatory testing: current best scientific practices for the evaluation of safety and potency of biologicals. ILAR. I 43(Suppl) S43\u2014S48 (2002).","DOI":"10.1093\/ilar.43.Suppl_1.S43"},{"key":"e_1_2_1_60_1","first-page":"1047","article-title":"Feayers I","volume":"22","author":"Jodar L","year":"2004","unstructured":"Jodar L, Griffiths E, Feayers I. Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines. Vaccine 22,1047\u20131053 (2004).","journal-title":"Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines. Vaccine"},{"key":"e_1_2_1_61_1","unstructured":"\u2022\u2022 Describes in detail the current WorldHealth Organization (WHO) recommendations for control and lot release of MenC conjugate vaccines."},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.200"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13494-0"},{"issue":"5","key":"e_1_2_1_64_1","first-page":"S20\u2014S27","article-title":"Meningococcal disease and vaccination in North America","volume":"37","author":"Pollard AJ","year":"2001","unstructured":"Pollard AJ, Scheifele D. Meningococcal disease and vaccination in North America. Pediatr. Child Health 37(5), S20\u2014S27 (2001).","journal-title":"Pediatr. Child Health"},{"issue":"1","key":"e_1_2_1_65_1","first-page":"40","article-title":"Genotype-specific carriage of Neisreria meningitidis in Georgia counties with hyper-and hyposporadic rates of meningococcal disease. J Infect","volume":"186","author":"Kellerman SE","year":"2002","unstructured":"Kellerman SE, McCombs K, Ray M et al. Genotype-specific carriage of Neisreria meningitidis in Georgia counties with hyper-and hyposporadic rates of meningococcal disease. J Infect. Dis. 186(1), 40\u201348 (2002).","journal-title":"Dis"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","unstructured":"Mayer LW Reeves MW al. Hamdan N et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J. Infect. Dis. 185(11) 1596\u20131605 (2002).","DOI":"10.1086\/340414"},{"key":"e_1_2_1_67_1","unstructured":"Issa M Moiling P Unemo M et al. Neisseria meningitidisserogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. Scand. J Infect. Dis. 35(4) 230\u2013233 (2003)."},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13171-6"},{"key":"e_1_2_1_69_1","doi-asserted-by":"crossref","unstructured":"Granoff DM. Assessing efficacy of Haemophilus intluenzaetype b combination vaccines. Clin. Infect. Dis. 33\\(Suppl. 4) S278\u2014S287 (2001).","DOI":"10.1086\/322563"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.3.5.533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:42:39Z","timestamp":1770896559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.3.5.533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1586\/14760584.3.5.533"],"URL":"https:\/\/doi.org\/10.1586\/14760584.3.5.533","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}